Research Article
Genetic Toxicology and Safety Pharmacological Evaluation of Forsythin
Table 2
Results of the chromosomal aberrations test for forsythin.
| Group | Dosage (µg/ml) | Number of cells scored | No. of cells with aberrations | −S9 | +S9 | 24 h | 48 h | 6–18 h |
| DMSOa | — | 200 | 4.0 | 2.5 | 2.0 | Mitomycin Cb | 0.25 | 200 | 14.5 | 18.5 | | Cyclophosphamideb | 20 | 200 | | | 19.0 | Forsythin | 125 | 200 | 5.0 | 2.5 | 5.0 | 250 | 200 | 4.5 | 1.5 | 5.0 | 500 | 200 | 5.0 | 5.0 | 4.5 |
|
|
aNegative control. bPositive control. , compared with the negative control group. , compared with the negative control group. |